The 20 Best Retinitis Pigmentosa Doctors near New York, NY

Dr. Yannuzzi has made numerous innovative and lasting contributions in imaging, drug development, and therapeutic modalities. He was the first to use oral non-steroid anti-inflammatory medication for the treatment of cystoid macular edema and developed an eye drop to treat this condition. He has described new diseases as well as new associations and manifestations of established entities and photosensitization.He has published over 400 scientific papers and 13 books, which have earned him respect and admiration in the ophthalmic-retinal community and retina specialists internationally. He is well recognized as a devoted and excellent educator, a superb clinical diagnostician, and a prolific organizer of retinal meetings worldwide. Dr. Yannuzzi is rated as an Advanced provider by MediFind in the treatment of Retinitis Pigmentosa. His top areas of expertise are Central Serous Chorioretinopathy, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Adult-Onset Vitelliform Macular Dystrophy (AVMD), and Vitrectomy.

Dr. Cooney is a practicing vitreoretinal surgeon who was previously an assistant professor of ophthalmology at Johns Hopkins University and later became the director of the Medical Retina Service, the Duke Center for Macular Degeneration, and the medical retina fellowship program from 2001 to 2005. He received a MBA degree from Kenan-Flagler Business School at the University of North Carolina, Chapel Hill.Dr. Cooney serves as a consultant and advisory board member for several pharmaceutical companies. In 1998, Dr. Cooney helped to establish InnoRx, an ophthalmic drug delivery and pharmaceutical company acquired by SurModics and served as a consultant from 2000 to 2002.Dr. Cooney’s clinical practice focuses on the medical and surgical treatment of vitreoretinal diseases, particularly age-related macular degeneration and diabetic retinopathy. He is actively involved in the clinical development of new diagnostic and therapeutic modalities for vitreoretinal disease and the training of residents and fellows.,Dr. Cooney helped establish InnoRx, an ophthalmic drug delivery and pharmaceutical company acquired by SurModics. Dr. Cooney is rated as an Experienced provider by MediFind in the treatment of Retinitis Pigmentosa. His top areas of expertise are Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Doyne Honeycomb Retinal Dystrophy, and Cone Dystrophy.

Richard Rosen is an Ophthalmologist in New York, New York. Dr. Rosen is rated as a Distinguished provider by MediFind in the treatment of Retinitis Pigmentosa. His top areas of expertise are Retinitis Pigmentosa, X-Linked Retinitis Pigmentosa (XLRP), Endophthalmitis, and Cone Dystrophy.

Susan Fromer is an Ophthalmologist in New York, New York. Dr. Fromer is rated as an Experienced provider by MediFind in the treatment of Retinitis Pigmentosa. Her top areas of expertise are Glaucoma, Kallikrein Hypertension, Allergic Conjunctivitis, and Meibomianitis.

Golnaz Moazami is an Ophthalmologist in New York, New York. Dr. Moazami is rated as an Advanced provider by MediFind in the treatment of Retinitis Pigmentosa. Her top areas of expertise are Optic Atrophy Type 1, Optic Nerve Atrophy, Ocular Hypertension (OHT), and Fourth Cranial Nerve Palsy.

David C. Ritterband MD, FACS is a Professor of Ophthalmology at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. Prior to joining Manhattan Eye, Ear and Throat Hospital (MEETH)/Northwell Eye Institute, he was a Professor of Ophthalmology at the Icahn School of Medicine at Mt Sinai and System Director of the Refractive Surgery Service for the Mount Sinai Health System. At MEETH he has assumed leadership of the Refractive Surgery division and the Laser Vision Correction Center and sees patients at the Manhattan Eye, Ear and Throat Hospital on 64th Street. Dr. Ritterband is a graduate of Duke University and received his medical degree at New York Medical College where he was elected to Alpha Omega Alpha, the national medical honor society. He completed his Ophthalmology Residency at New York Medical College where he was elected Chief Resident. He completed his Corneal and External disease and Refractive Surgery Fellowship at the University of Pittsburgh School of Medicine Eye and Ear Institute. He is a fellow of the American Academy of Ophthalmology and the American College of Surgeons. He is a past president of the Ocular Microbiology and Immunology Group and a long time Medical Board member of the Eye Bank for Sight Restoration in New York City, the world's first Eye Bank. In addition to maintaining a busy tertiary-care referral practice in New York City, Dr. Ritterband is a nationally recognized physician, scientist, and surgeon. He has published over 250 medical and scientific papers, book chapters, monographs, and research abstracts. He has lectured widely in the United States on cornea, cataract, and refractive surgery topics. His clinical and research interests include cornea transplantation, cataract surgery, ocular drug development, laser refractive surgery, and ocular infections. A committed teacher and mentor, he has trained over 50 clinical cornea fellows first at the highly regarded AUPO certified corneal fellowship program at the New York Eye and Ear Infirmary and continuing with the current AUPO corneal fellowship program at Manhattan Eye, Ear and Throat Hospital. Dr. Ritterband has received numerous awards including an Honor Award from the American Academy of Ophthalmology and has been named multiple times to New York Magazine's Best Doctors, Castle Connolly's Top Doctors, and the NY Times Magazine's Super Doctors. In addition, while at the New York Eye and Ear Infirmary he received 6 Resident Outstanding Teaching and Dedicated Service Awards. Dr. Ritterband is rated as an Experienced provider by MediFind in the treatment of Retinitis Pigmentosa. His top areas of expertise are Cataract, Endophthalmitis, Interstitial Keratitis, Corneal Transplant, and Trabeculectomy.

John Seedor is an Ophthalmologist in New York, New York. Dr. Seedor is rated as an Experienced provider by MediFind in the treatment of Retinitis Pigmentosa. His top areas of expertise are Fuchs Dystrophy, Interstitial Keratitis, Corneal Dystrophy and Perceptive Deafness, Corneal Transplant, and Trabeculectomy.

Talia Kaden is a General Surgeon and an Ophthalmologist in New York, New York. Dr. Kaden is rated as an Experienced provider by MediFind in the treatment of Retinitis Pigmentosa. Her top areas of expertise are Retinal Detachment, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Vitrectomy, and Iridectomy.

David Rubaltelli is an Ophthalmologist in Brooklyn, New York. Dr. Rubaltelli is rated as an Experienced provider by MediFind in the treatment of Retinitis Pigmentosa. His top areas of expertise are Diabetic Retinopathy, Kallikrein Hypertension, Congenital Toxoplasmosis, and Late-Onset Retinal Degeneration.

Louis Angioletti is an Ophthalmologist in New York, New York. Dr. Angioletti is rated as an Experienced provider by MediFind in the treatment of Retinitis Pigmentosa. His top areas of expertise are Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Geographic Atrophy, and Retinal Vein Occlusion.

Scott E. Brodie, MD, Ph.D., is a Professor of Clinical Ophthalmology and Attending Ophthalmologist in the Department of Ophthalmology. He is an internationally known clinician-scientist, and a leader in the use of electrophysiologic techniques for diagnosing of visual impairments in children and adults.Dr. Brodie is a graduate of the combined MD-PhD program at Weill-Cornell Medical College and The Rockefeller University in New York. He completed his PhD in retinal physiology in the laboratory of Nobel Laureate H. K. Hartline, under the supervision of Dr. Floyd Ratliff and Prof. Bruce Knight. He completed a medical internship and residency training in ophthalmology at The New York Hospital, and subsequently received fellowship training in medical retinal disorders and clinical electrophysiology of vision at New York University and Bellevue Hospital under the supervision of Dr. Ronald Carr, with support as a John Kluge Fellow of the Retinitis Pigmentosa Foundation.He is a fellow of the American Academy of Ophthalmology, and a fellow of the Association for Research in Vision and Ophthalmology. He is a member of the International Society for Clinical Electrophysiology of Vision, the International Society for Genetic Eye Disease, and the Ophthalmic Genetics Study Club. Dr. Brodie has been honored with the Senior Achievement Award of the American Academy of Ophthalmology, as well as the Academy's Secretariat Award for Education.Dr. Brodie’s research centers on improving methodologies for electrophysiologic testing, and descriptions of novel findings in patients with inherited and metabolic retinal disorders. He has been a key member of the teams which have introduced important new therapies, including enzyme-replacement therapy for Fabry disease, and intra-arterial chemotherapy for retinoblastoma, which has increased the rate of salvage of diseased eyes in the most severely affected patients from 20% to over 90%.Dr. Brodie has published extensively on electrophysiology and retinal disorders. He has a particular interest in clinical optics, and has served as Chair of the Editorial committee for the American Academy of Ophthalmology’s Basic and Clinical Science Course on Clinical Optics for the past ten years. In his spare time, he enjoys reading mathematics, and playing the oboe in local orchestras and chamber groups. Dr. Brodie is rated as a Distinguished provider by MediFind in the treatment of Retinitis Pigmentosa. His top areas of expertise are Retinoblastoma, Retinitis Pigmentosa, Cone-Rod Dystrophy, Retinopathy Pigmentary Mental Retardation, and Vitrectomy.

"Stephen H. Tsang, M.D, Ph.D. is an acclaimed clinical geneticist in the care of individuals with retinal degenerations. He has been culturing stem cells since 1992 and created the first mouse model for a recessive form of retinitis pigmentosa (RP) by applying genome engineering to stem cell technology in 1995. He successfully treated preclinical models of Pde6a, Pde6b, Mfrp, Rho, Cngb1 and autosomal recessive bestrophin retinopathies.He has expertise in designing and testing genome engineering strategies in pre-clinical models, developing patient-specific knock-in models, generating of patient cell lines and providing care to patients with a precision medicine approach. He is also leading efforts in FDA trials for gene therapies, including PDE6A, RAB geranylgeranyl transferase, RPGR, CNGB3, CNGA3 and ABCA4 retinopathies. He wrote 3 books: “Precision Medicine, CRISPR, and Genome Engineering: Moving from Association to Biology and Therapeutics"" and “Stem Cell Biology and Regenerative Medicine in Ophthalmology”, Springer Press, NY; and “CRISPR Genome Surgery in Stem Cells and Disease Tissues”, Elsevier Inc. He is an elected member of several honorary societies including the American Society for Clinical Investigation, Alcon Research Institute and American Ophthalmological Society. He is consistently named to various NIH study sections (DPVS standing member 2014-8 and PED2 2022-6) and other review committees; Alcon Research Institute Grant Review Committee (2022-27), Scientific Advisory Panel - Research to Prevent Blindness (RPB, 2019-29), Chair of American Ophthalmological Society Thesis Review Committee (2022-2023). Many of his publications are in widely-read general interest journals such as Science, NEJM, Lancet, Cell Stem Cell, Nature Genetics, and Journal of Clinical Investigation, which attests to the broad impact that his work has had.Dr. Tsang received a resident teaching award in 2008 and was the Columbia Ophthalmology Basic Science Course Director (2006-2018). Dr. Tsang graduated from Johns Hopkins University, where he began his medical genetics training under the tutelage of Professor Victor A. McKusick. He received his M.D. and Ph.D. degrees from the NIH-National Institute of General Medical Sciences Medical Scientist Training Program (MSTP) at Columbia University. Dr. Tsang then completed his residency at Jules Stein Eye Institute/UCLA, followed by studies with Professors Alan C. Bird and Graham E. Holder on improving the care of individuals with macular degenerations.". Dr. Tsang is rated as a Distinguished provider by MediFind in the treatment of Retinitis Pigmentosa. His top areas of expertise are Retinopathy Pigmentary Mental Retardation, Sorsby Fundus Dystrophy, Leber Congenital Amaurosis, and Usher Syndrome.

Dr. Spaide specializes in diseases of the retina and vitreous. His particular interests include retinal surgery, Macular Degeneration, Macular Holes, Macular Pucker, Diabetic Retinopathy, and intraocular inflammation. He has published more than 300 articles and 50 book chapters and 9 books about the diagnosis and treatment of Retinal Diseases. He has given lectures around the world.He has a remarkable number of “firsts” in retinal diseases including the development of autofluorescence imaging using a fundus camera and the first practical method to image deeper structures in the eye with optical coherence tomography. These imaging methods now are used around the world. He has described many new findings and diseases of the eye and helped develop many novel treatments. He has developed numerous surgical instruments that were named after him and holds patents for ophthalmic inventions.He is the recipient of the Richard and Hilda Rosenthal Foundation Award in the Visual Sciences, the Senior Honor Award from the American Society of Retinal Surgeons, and the Senior Achievement Award from the American Academy of Opthalmology and the Prix Soubrane de la Recherche en Ophthalmologie, Award of Merit from the Retina Society, the Henkind Award, Coscas Award, Nataraja Pillai Award, W. Richard Green MD Award, George Theodossiadis Award, Founders Award, American Society of Retinal Surgeons, Life Achievement Honor Award, and the American Academy of Ophthalmology. Dr. Spaide is rated as an Experienced provider by MediFind in the treatment of Retinitis Pigmentosa. His top areas of expertise are Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Central Serous Chorioretinopathy, Geographic Atrophy, and Vitrectomy.

Ian Chan is an Ophthalmologist in New York, New York. Dr. Chan is rated as an Advanced provider by MediFind in the treatment of Retinitis Pigmentosa. His top areas of expertise are Retinal Vein Occlusion, Retinal Artery Occlusion, Neuroretinitis, and Late-Onset Retinal Degeneration.

Yasha Modi is an Ophthalmologist in Brooklyn, New York. Dr. Modi is rated as an Advanced provider by MediFind in the treatment of Retinitis Pigmentosa. His top areas of expertise are Retinal Vein Occlusion, Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Vitrectomy, and Cataract Removal.

John Khadem is an Ophthalmologist in New York, New York. Dr. Khadem is rated as an Advanced provider by MediFind in the treatment of Retinitis Pigmentosa. His top areas of expertise are Retinal Detachment, Central Serous Chorioretinopathy, Late-Onset Retinal Degeneration, and Age-Related Macular Degeneration (ARMD).

Gennady Landa is an Ophthalmologist in New York, New York. Dr. Landa is rated as an Advanced provider by MediFind in the treatment of Retinitis Pigmentosa. His top areas of expertise are Retinal Detachment, Diabetic Retinopathy, Age-Related Macular Degeneration (ARMD), Vitrectomy, and Cataract Removal.

Richard Koplin is an Ophthalmologist in New York, New York. Dr. Koplin is rated as an Advanced provider by MediFind in the treatment of Retinitis Pigmentosa. His top areas of expertise are Autosomal Dominant Vitreoretinochoroidopathy, Norrie Disease, Wagner Syndrome, Cataract, and Cataract Removal.

Anthony Curreri is an Ophthalmologist in New York, New York. Dr. Curreri is rated as an Advanced provider by MediFind in the treatment of Retinitis Pigmentosa. His top areas of expertise are Ocular Hypertension (OHT), Conjunctivitis (Pink Eye), Glaucoma, and Pinguecula.

Dr. Klancnik utilizes all forms of ophthalmic imaging including fluorescein angiography, indocyanine green angiography, as well as noninvasive forms of imaging such as spectral domain optical coherence tomography, autofluorescence photography, and ultrasonography.Dr. Klancnik is a magna cum laude graduate of Yale University. He earned his medical degree from Jefferson Medical College of Thomas Jefferson University and was elected to the Alpha Omega Alpha and Hobart Amory Hare honor medical societies. He completed his internship at the Lankenau Hospital and his ophthalmology residency at Wills Eye Hospital. He completed his medical and surgical vitreoretinal fellowship at Manhattan Eye, Ear & Throat Hospital and Columbia University. He is an Assistant Professor of Clinical Ophthalmology at New York University School of Medicine.Dr. Klancnik is a member of numerous medical organizations including the American Academy of Ophthalmology, American Society of Retinal Specialists, and Association for Research in Vision and Ophthalmology. He is an author of numerous peer-reviewed journal articles and book chapters and has presented at scientific meetings nationally and internationally. He is active in numerous clinical trials as principle or sub-investigator and serves as a reviewer for several ophthalmology journals. Dr. Klancnik is rated as an Experienced provider by MediFind in the treatment of Retinitis Pigmentosa. His top areas of expertise are Central Serous Chorioretinopathy, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), and Retinal Vein Occlusion.